ICICI Bank Limited Common Stock vs Twist Bioscience Corp — how do they compare? ICICI Bank Limited Common Stock trades at $27.88 (market cap $100.09B), while Twist Bioscience Corp trades at $161.11 (market cap $10.08B). The key difference: ICICI Bank Limited Common Stock is far larger — about 9.9× Twist Bioscience Corp's market cap, and ICICI Bank Limited Common Stock pays a 0.9% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold ICICI Bank Limited Common Stock for 1 Days and Twist Bioscience Corp for 27 Days on average.
| IBN | TWST | |
|---|---|---|
Market Cap | $100.09B | $10.08B |
Volume | 5,088,983 | 4,229,037 |
Sector | Financials | Health |
52-Week High | $32.94 | $205.00 |
52-Week Low | $25.20 | $25.45 |
Typical Hold Time | 1 Days | 27 Days |
Enterprise Value | $10.03T | $10.01B |
Dividend Yield | 0.9% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Twist Bioscience (TWST) trades at $159.78, up 2.65% today, showing strong momentum despite mixed technical signals. The company continues to demonstrate robust revenue growth, with 2025 revenue reaching $377 million, though profitability remains elusive with a -31.66% net income margin. Recent positive developments include a strategic partnership with Eli Lilly's TuneLab AI platform announced September 16, 2026, driving investor optimism about the company's AI-driven drug discovery capabilities.
While analyst consensus remains bullish with 73% buy ratings, the stock faces significant fundamental challenges including persistent cash burn and negative earnings. The current price exceeds the $145.20 consensus target, suggesting limited near-term upside. Key risks include execution challenges in achieving profitability and dependence on AI partnerships for growth catalysts.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
ICICI Bank is an Indian financial services company providing banking, lending, cards, insurance, and investment products. It serves retail, business, and corporate customers.
Read more on IBN →Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →